Published in Rheumatol Int on January 10, 2014
IgG4-Related Disease: Results From a Multicenter Spanish Registry. Medicine (Baltimore) (2015) 0.92
Consensus statement on the pathology of IgG4-related disease. Mod Pathol (2012) 9.01
Prednisone versus tamoxifen in patients with idiopathic retroperitoneal fibrosis: an open-label randomised controlled trial. Lancet (2011) 3.19
Retroperitoneal fibrosis: a clinicopathologic study with respect to immunoglobulin G4. Am J Surg Pathol (2009) 1.63
Idiopathic retroperitoneal fibrosis: a retrospective review of clinical presentation, treatment, and outcomes. Mayo Clin Proc (2011) 1.34
Histopathologic and clinical subtypes of autoimmune pancreatitis: the honolulu consensus document. Pancreatology (2011) 1.20
Rethinking Ormond's disease: "idiopathic" retroperitoneal fibrosis in the era of IgG4-related disease. Medicine (Baltimore) (2013) 1.08
Idiopathic retroperitoneal fibrosis: a clinicopathological study in 24 Spanish cases. Clin Rheumatol (2013) 0.81
Degree of IgG4+ plasma cell infiltration in retroperitoneal fibrosis with or without multifocal fibrosclerosis. Histopathology (2008) 0.80
Usefulness of anti-p155 autoantibody for diagnosing cancer-associated dermatomyositis: a systematic review and meta-analysis. Arthritis Rheum (2012) 2.08
Tacrolimus in the treatment of chronic and refractory late-onset immune-mediated adverse effects related to silicone injections. Dermatol Surg (2011) 1.46
Delayed immune-mediated adverse effects of polyalkylimide dermal fillers: clinical findings and long-term follow-up. Arch Dermatol (2008) 1.41
The neural network as a predictor of cancer in patients with inflammatory myopathies. Arthritis Rheum (2002) 1.40
[Neuropsyquiatric manifestations in systemic lupus erythematosus]. Med Clin (Barc) (2009) 1.39
Occupational exposure in patients with the antisynthetase syndrome. Clin Rheumatol (2014) 1.37
Conventional cancer screening versus PET/CT in dermatomyositis/polymyositis. Am J Med (2010) 1.22
Implication of human endogenous retroviruses in the development of autoimmune diseases. Int Rev Immunol (2010) 1.18
Nailfold capillary microscopy in adults with inflammatory myopathy. Semin Arthritis Rheum (2008) 1.18
Effect of mycophenolate sodium in scleroderma-related interstitial lung disease. Clin Rheumatol (2011) 1.17
Efficacy and safety of lenalidomide for refractory cutaneous lupus erythematosus. Arthritis Res Ther (2012) 1.09
Molecular mechanisms mediated by human endogenous retroviruses (HERVs) in autoimmunity. Rev Med Virol (2009) 1.08
Antihistone and anti-double-stranded deoxyribonucleic acid antibodies are associated with renal disease in systemic lupus erythematosus. Am J Med (2004) 1.05
DNA methylation and systemic lupus erythematosus. Ann N Y Acad Sci (2007) 1.00
Transcript levels of DNA methyltransferases DNMT1, DNMT3A and DNMT3B in CD4+ T cells from patients with systemic lupus erythematosus. Immunology (2008) 0.97
Myositis-specific and myositis-associated antibodies in a series of eighty-eight Mediterranean patients with idiopathic inflammatory myopathy. Arthritis Rheum (2006) 0.94
Case report: retroperitoneal fibrosis simulating local relapse of sarcomatoid renal cell carcinoma. Int Urol Nephrol (2006) 0.92
Cancer-associated myositis and anti-p155 autoantibody in a series of 85 patients with idiopathic inflammatory myopathy. Medicine (Baltimore) (2010) 0.92
IgG4-Related Disease: Results From a Multicenter Spanish Registry. Medicine (Baltimore) (2015) 0.92
Anti-TIF1γ antibodies (anti-p155) in adult patients with dermatomyositis: comparison of different diagnostic assays. Ann Rheum Dis (2012) 0.89
Transcript overexpression of the MBD2 and MBD4 genes in CD4+ T cells from systemic lupus erythematosus patients. J Leukoc Biol (2007) 0.89
Registry of the Spanish network for systemic sclerosis: clinical pattern according to cutaneous subsets and immunological status. Semin Arthritis Rheum (2011) 0.87
Celiac disease and antibodies associated with celiac disease in patients with inflammatory myopathy. Muscle Nerve (2007) 0.87
Serum levels of soluble CD40 ligand at flare and at remission in patients with systemic lupus erythematosus. J Rheumatol (2009) 0.86
The complex immunogenetic basis of systemic lupus erythematosus. Autoimmun Rev (2008) 0.86
Age-related survival and clinical features in systemic sclerosis patients older or younger than 65 at diagnosis. Rheumatology (Oxford) (2010) 0.82
Genetic risk factors of thrombosis in the antiphospholipid syndrome. Br J Haematol (2009) 0.82
Are bacterial growth and/or chemotaxis increased by filler injections? Implications for the pathogenesis and treatment of filler-related granulomas. Dermatology (2010) 0.82
Cardiac manifestations other than valvulopathy in antiphospholipid syndrome: long-time echocardiography follow-up study. Int J Rheum Dis (2013) 0.81
Delayed immune-mediated adverse effects related to polyacrylamide dermal fillers: clinical findings, management, and follow-up. Dermatol Surg (2009) 0.81
Idiopathic retroperitoneal fibrosis: a clinicopathological study in 24 Spanish cases. Clin Rheumatol (2013) 0.81
Calcineurin inhibitors in a cohort of patients with antisynthetase-associated interstitial lung disease. Clin Exp Rheumatol (2013) 0.81
Protein Z levels and anti-protein Z antibodies in patients with arterial and venous thrombosis. Thromb Res (2007) 0.80
Anti-cyclic citrullinated peptide and anti-keratin antibodies in patients with idiopathic inflammatory myopathy. Rheumatology (Oxford) (2009) 0.80
DNASE I mutation and systemic lupus erythematosus in a Spanish population: comment on the article by Tew et al. Arthritis Rheum (2002) 0.79
Associations between the expression of epigenetically regulated genes and the expression of DNMTs and MBDs in systemic lupus erythematosus. PLoS One (2012) 0.79
Xenotropic murine leukemia virus-related virus (XMRV) in patients with systemic lupus erythematosus. J Clin Immunol (2011) 0.79
Venous thromboembolism in patients with dermatomyositis and polymyositis. Clin Exp Rheumatol (2011) 0.79
Clinical and serological findings associated with the expression of ITGAL, PRF1, and CD70 in systemic lupus erythematosus. Clin Exp Rheumatol (2013) 0.78
Health-related quality of life and well-being in adults with idiopathic inflammatory myopathy. Clin Rheumatol (2014) 0.78
Changes in lipid profile between flare and remission of patients with systemic lupus erythematosus: a prospective study. J Rheumatol (2009) 0.77
Obstructive sleep apnea in patients with inflammatory myopathies. Muscle Nerve (2009) 0.77
Acquired haemophilia A: successful treatment with immunosuppression, methylprednisolone pulses and oral cyclosporin. Thromb Haemost (2006) 0.76
[Atherosclerosis and anti-oxidized low density lipoprotein antibodies in an elderly population]. Med Clin (Barc) (2002) 0.76
Correlation of ultrasound B-lines with high-resolution computed tomography in antisynthetase syndrome. Clin Exp Rheumatol (2014) 0.76
Enhanced transcript levels of CD48 in CD4⁺ T cells from systemic lupus erythematosus patients. Immunobiology (2011) 0.75
[Clinical features and prognosis of patients with scleroderma renal crisis]. Med Clin (Barc) (2011) 0.75
Nephrotic syndrome and lambda light-chain monoclonal gammopathy suggestive of primary amyloidosis with positive staining for AA amyloid. J Am Geriatr Soc (2012) 0.75
Epstein-Barr virus-associated lymphoma in patients with dermatomyositis. Be aware of double immunosuppression. Rheumatology (Oxford) (2009) 0.75
Churg-Strauss Syndrome: an evolving paradigm. Autoimmun Rev (2012) 0.75
[Diagnosis: pericardial fat necrosis]. Med Clin (Barc) (2007) 0.75
A 21-year-old girl with recurrent abdominal pain after a robbery. Lancet (2005) 0.75